Enhanced Group Inc. (ENHA) Q3 2026 earnings review
Enhanced buys a European concert business, but cash runs low
Enhanced Group, which runs medically enhanced sports events and an online clinic, is buying a European concert promoter while its own cash runs low. Revenue dropped from $17.7 million during May's inaugural Games to $3.3 million, and chief executive Maximilian Martin called the quarter a pause before buying 77% of DEAG Deutsche Entertainment AG. That all-stock acquisition and a $15 million share sale bring a 2027 outlook of $670 million in combined revenue, but they also add about 13.1 million Class A shares to an existing base of 13.8 million.
| Revenue | $3.3M $17.7M last quarter ($0 a year ago) |
|---|---|
| Operating cash burn (Q3) | $26.0M by our math; $12.1M cash left |
| Upcoming Class A share issuance | +13.1M shares +95% dilution on 13.8M current shares |
| 2027 combined outlook (with DEAG) | ~$670M sales ~$26M profit before one-offs |
⚖️ Verdict: 🔴 Bearish
The story got worse because cash burn and dilution accelerated while the online clinic's sales remained undisclosed. By our math the business burned $26 million of operating cash in the quarter, ending September with $12 million in cash against $25 million in unpaid bills, and ongoing overhead of $8 million missed finance chief Sid Banthiya's $5.5 million baseline. On the positive side, the team launched its Enhanced OS health software and six prescription peptides on schedule, and DEAG brings a profitable live-events business once the deal closes.
The question now is whether the DEAG purchase and telehealth ramp create a self-funding business or simply mask ongoing cash losses at the original sports and clinic operations. Either the online clinic scales into the double-digit millions next year while event costs stay capped, or the parent company requires further stock sales after existing Class A shareholders have already been diluted nearly in half. First-quarter 2027 segment reporting and year-end cash collections from sponsors will settle it.
🐂 Bull Case
Buying a European Ticketing Business Changes the Company
Enhanced Group, which runs sports events for athletes using medical enhancements and sells online prescriptions, agreed to buy 77% of DEAG Deutsche Entertainment AG. DEAG is a European concert promoter and ticketing business that stages about 6,000 live events a year. Management expects the deal to close in the first quarter of 2027 and "completely change the financial profile of Enhanced Group".
- Combined 2027 revenue outlook: about $670 million, up 21.5% from 2026 by our math
- DEAG 2027 profit before interest, taxes, depreciation and one-offs: about $26.5 million
- Combined 2027 profit on the same basis: about $26 million
- Purchase price: about 11 million Class A shares at $8.00 each, valuing DEAG at $139 million including debt
This matters because DEAG supplies all of the group's projected 2027 profit. By our math, subtracting DEAG's $26.5 million from the $26 million combined target leaves the existing sports and telehealth operations slightly below breakeven. One caution sits in the footnotes: Enhanced prepared the 2027 numbers on its own, and "DEAG has not participated in their preparation, and they are not guidance, forecasts or projections provided, approved, adopted or endorsed by DEAG or its management".
What to watch: the closing of the DEAG purchase in the first quarter of 2027 and the first audited conversion of DEAG's European accounts into US accounting rules. That filing will show how much cash DEAG actually generates after interest, taxes and debt rules limit what the parent company can use.
Health Software and Six New Peptides Launch on Schedule
Enhanced wants Live Enhanced, its online clinic for performance medicine, to become a recurring consumer business alongside its sporting events. On November 12, the company launched a test version of Enhanced OS, its software designed to "combine medical records, biomarkers testing and wearable data into individualized health plans". It also added Modafinil and six prescription peptides to its existing 12 medical treatments, though tightening federal rules on compounded peptides remain a standing risk.
Delivering both the software and the new treatments on time gives the clinic a broader menu before management steps up advertising at the end of the year. Finance chief Sid Banthiya said the business tripled its marketing efficiency and expects 2027 telehealth sales to "reach well into the double-digit millions".
What to watch: standalone telehealth revenue when the company begins full segment reporting in the first quarter of 2027. That disclosure will prove whether the new software and peptide prescriptions are winning paying subscribers at the pace the 2027 target requires.
Smaller Events and a $20 Million Cap Cut Sports Costs
Staging the first Enhanced Games in May cost $52.0 million in event and athlete expenses, which drove a $61.9 million second-quarter loss and drew criticism over few world records. To stay visible without spending at that level again, Enhanced launched smaller single-sport contests called Enhanced Breakers that "operate at a fraction of the cost of a flagship Enhanced Games event".
At the first Breakers contest, weightlifter Beatriz Piron set a new world record in the snatch six weeks after an injury kept her out of the May Games, answering critics of the medical programme. Event and athlete costs dropped from 294.0% of revenue in the second quarter to 80.8% in the third quarter, and management set a $20 million budget for the 2027 Games so the sports division can break even next year.
What to watch: total event expenses in the fourth quarter, which includes the December 19 swimming contest in Las Vegas. Holding quarterly event costs near $3 million will confirm that the smaller contests can run cheaply while management prepares the 2027 flagship event.
🐻 Bear Case
Cash Fell to $12 Million and Deals Will Double the Share Count
Chief executive Maximilian Martin said Enhanced is "fully financed for growth" after signing the DEAG purchase and a concurrent $15 million share sale to private investors. Yet the balance sheet remains stretched because paying bills from the May Games consumed cash throughout the summer. By our math, subtracting six-month operating cash burn of $44.0 million from the nine-month total of $70.0 million shows the business burned $26.0 million of operating cash in the third quarter alone.
- Cash on hand: $12.1 million at September 30, down from $19.6 million in June
- Unpaid bills and accrued expenses: $25.4 million, more than double the cash balance
- Current Class A shares with economic ownership: 13.8 million after the one-for-ten reverse split
- Upcoming Class A share issuances in Q1 2027: about 13.1 million for DEAG and the $15 million financing
Because the company lacked the cash to pay for growth or acquisitions out of pocket, it is paying with stock. Issuing 11 million shares for DEAG and 2.1 million shares for the $15 million cash raise increases the economic share count by 95% by our math, cutting existing shareholders' slice of the business nearly in half.
What to watch: year-end cash and unpaid bills in the 2026 annual report. Even if the $15 million stock sale and $20 million of sponsorship money arrive on time, paying down $25.4 million of bills alongside fourth-quarter losses will leave a narrow cash cushion.
Telehealth Sales Stay Hidden While Overhead Beats the Target
"We have deliberately held back on aggressively scaling our telehealth platform so far, as we wanted to get the product mix right, optimize the unit economics and build something that offers more than just an online pharmacy," Banthiya said. Management also cited operating discipline after the May Games and last quarter told investors that ongoing overhead — selling, general and administrative costs excluding stock compensation and non-cash advertising with video platform Rumble — should run near $5.5 million a quarter.
The third-quarter numbers cut against both claims. Enhanced reported $3.3 million of total revenue, mixing telehealth orders with remaining sponsorship money, and gave no customer count, order volume or dollar figure for the clinic. Meanwhile, overhead rose to 384.9% of revenue from 94.0% in the second quarter. Stripping $3.1 million of Rumble advertising and $1.5 million of stock compensation from $12.7 million of overhead leaves $8.1 million by our math, 48% above Banthiya's $5.5 million target.
What to watch: the first segment breakdown in the first quarter of 2027 and fourth-quarter overhead excluding one-offs. Until management prints a separate telehealth revenue line and brings quarterly cash overhead down toward $5.5 million, neither the consumer growth story nor the cost discipline is proven.
Sponsorship Cash Relies on Unpaid Bills and Locked Shares
Because the annual Enhanced Games took place in May, total revenue dropped 81% from $17.7 million in the second quarter to $3.3 million in the third quarter. Furthermore, much of the sponsorship revenue booked this year has not yet turned into spendable cash, and the company recorded $20.1 million of non-cash sponsorship revenue across the first nine months of 2026.
To bolster its cash before year-end, Enhanced is counting on $20 million from two sponsors in December: a $10 million cash payment due December 31 from title sponsor Zoop, and $10 million of ordinary shares in Rezolve that unlock on December 23. Relying on a single day's payment from Zoop and the sale of another company's stock creates collection and price risk right when cash is tightest.
What to watch: actual cash collected from Zoop and proceeds from selling the Rezolve shares by December 31, 2026. Any delay in Zoop's payment or a drop in Rezolve's share value before the lock-up expires would shrink the $20 million cash inflow management expects.
👓 Other Themes
Reverse Split, Lock-Up Extension and AI Leisure Bet
Enhanced completed a one-for-ten reverse stock split on October 29, leaving 13.8 million Class A economic shares and 25.9 million voting-only Class B shares. Key shareholders including Martin extended their resale restriction on 3.1 million Class A shares to 12 months, cutting the November 8 unlock by 60%. Separately, Martin framed the DEAG live-events purchase around a macro view that artificial intelligence and robotics will reduce human labour and increase demand for live entertainment.
💲 Other KPIs
Event and athlete expenses fell 95% from $52.0 million in the second quarter, when Enhanced staged its inaugural Games in Las Vegas, but more than doubled from $1.3 million a year ago. Third-quarter spending consisted mainly of contracted pay for athletes between flagship events.
The company's contract asset — sponsorship revenue booked before payment arrives — dropped from $15.5 million in June to $3.1 million in September. Over the same period, marketable securities rose from zero to $8.1 million after Enhanced amended its Rezolve sponsorship into $10.0 million of Rezolve stock locked until December 23.
Deal and financing fees dropped from $10.9 million in the second quarter, when the company completed its public listing, to $1.2 million in the third quarter, up from $0.5 million a year ago. Third-quarter fees covered work on the DEAG acquisition, and nine-month transaction costs reached $13.7 million.
🔮 Guidance
New. Management expects the combined group to generate about $670 million in 2027 after consolidating 100% of DEAG in the first quarter. The sports and telehealth company stated this represents 21.5% growth from 2026, which by our math implies the two businesses together generate about $551 million in 2026, almost entirely from DEAG.
New. The plan calls for about $26 million in combined profit before interest, taxes, depreciation and one-offs, a $65.5 million improvement from 2026. Because Enhanced estimates DEAG's standalone 2027 figure at $26.5 million after deducting lease costs, the outlook implies the existing sports and telehealth operations lose about $0.5 million by our math.
New. Banthiya expects the online clinic to reach well into the double-digit millions in 2027 as marketing scales at the end of 2026 following the launch of Enhanced OS and six new peptides. Because the performance medicine group has not disclosed current quarterly telehealth sales, investors cannot yet measure the step-up required.
Unchanged in direction, now quantified. The operator set a $20 million budget for the 2027 Games, down 62% from the $52.0 million spent on event and athlete costs in the second quarter of 2026 by our math. With sponsorship, media rights, ticketing and host-city support, it plans for the sports division to at least break even.
❓ Key Questions
What were standalone telehealth sales and customer counts in Q3?
Total revenue was $3.3 million, mixing online clinic orders with sponsorship recognition. Without standalone telehealth revenue or active subscriber numbers prior to the 2027 segment reporting change, investors cannot test management's target of double-digit millions next year.
Why did clean overhead run $2.6 million above target?
Last quarter management pointed to $5.5 million as its ongoing quarterly overhead base excluding Rumble advertising and stock pay. By our math, that figure was $8.1 million in the third quarter even before counting $1.2 million of deal fees.
How much of DEAG's cash can fund the US business?
Enhanced will own 77% of DEAG and expects DEAG to continue its own acquisition strategy under incoming chief executive Markus Breitenecker. Management has not said whether debt agreements or minority shareholder rules allow DEAG to send cash to fund the sports and telehealth businesses.
Where and when will the 2027 Enhanced Games take place?
The company expects the sports business to break even in 2027 on a $20 million Games budget with host-city financial support, but has not announced a host city, a date or signed 2027 sponsorship contracts.